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Background
Women known to carry a BRCA1/2 mutation have to
make complex decisions regarding the management of
their increased cancer risk, such as whether or not to
undergo risk-reducing surgery and how to communicate
this risk information to family members. These women
may face a unique set of supportive care needs, although
unlike the situation for breast and other cancer patients,
few supportive care services for mutation carriers exist
outside the Familial Cancer Centres. The aim of this
presentation is to describe the unmet support needs of
women with a known BRCA 1/2 mutation volunteering
for a randomised control trial (RCT) testing the effec-
tiveness of a telephone based peer support program.
Methods
Participants were recruited through Familial Cancer
Centres in Victoria, New South Wales and South Aus-
tralia. Women between the ages of 18-70, who tested
positive for a BRCA1/2 mutation within the last 4 years
were eligible for participation in the study. Participants
were recruited as part of an ongoing RCT. Women
completed a baseline survey after enrolling in the study
and prior to randomisation. The baseline survey
included a 16-item scale assessing unmet support needs,
such as dealing with fears about developing cancer,
wanting reassurance that feelings are normal, and talk-
ing to others in a similar situation. Women were asked
to indicate their level of need in the past month on each
item using a 5-point likert scale.
Results
216 participants have completed the baseline survey to
date (response rate of 46%). The average age of partici-
pants was 47.2 years (SD:13.6) and 44.0% (n=95) had a
previous diagnosis of breast or ovarian cancer. The
mean time since notification of carrier status was 2.5
years (SD=2.1).
The average number of moderate to very high needs
among all participants was 4.7 (S.D 4.6). Twenty six per-
cent (n=52) of participants had no moderate to very
high needs, while 23.1% (n=46) had a moderate to very
high need on eight or more items. The most commonly
endorsed moderate to very high needs were: “dealing
with uncertainty about the future” (42%), “dealing with
the impact a faulty gene has had on your family” (40%),
and “dealing with fears about developing cancer” (39%).
The least endorsed items were: “dealing with insurance
issues” (61% indicated no need), “dealing with feelings
of isolation” (53% no need) and “obtaining more infor-
mation about your risk for breast cancer” (53%). The
average number of moderate to very high unmet needs
was not related to previous history of cancer (P=0.94),
having children (p=0.87) or time since receiving
BRCA1/2 mutation status results (P=0.36).
Discussion
Many women with a known BRCA 1/2 mutation have
unmet supportive care needs that are not currently
being addressed. Level of unmet need is not related to
time since receiving test results, history of cancer or
having children. The RCT trial will assess whether a tel-
ephone-based peer support program meets these unmet
needs.
Cancer Council Victoria, Australia
White et al. Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A54
http://www.hccpjournal.com/content/10/S2/A54
© 2012 White et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Published: 12 April 2012
doi:10.1186/1897-4287-10-S2-A54
Cite this article as: White et al.: What are the unmet support needs of
women with a known BRCA1/2 mutation? Hereditary Cancer in Clinical
Practice 2012 10(Suppl 2):A54.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
White et al. Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A54
http://www.hccpjournal.com/content/10/S2/A54
Page 2 of 2